Cargando…

Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients

Idiopathic pulmonary fibrosis (IPF) lacks effective treatment. Pirfenidone has been used to treat IPF patients. N-acetylcysteine (NAC) exerts antioxidant and antifibrotic effects on IPF cases. This study is a double-blind, modified placebo-controlled, randomized phase II trial of pirfenidone in Chin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Hui, Dai, Hua Ping, Kang, Jian, Chen, Bao Yuan, Sun, Tie Ying, Xu, Zuo Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	6700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620844/ https://www.ncbi.nlm.nih.gov/pubmed/26496265 http://dx.doi.org/10.1097/MD.0000000000001600

Ejemplares similares

Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration
por: Ikeda, Satoshi, et al.
Publicado: (2022)

Diagnostic finding on high-resolution computed tomography (HRCT) predicts a good response to pirfenidone in patients with idiopathic pulmonary fibrosis
por: Ma, Miao, et al.
Publicado: (2023)

Chinese herbal medicines for the treatment of cough in idiopathic pulmonary fibrosis: A protocol for systematic review and meta-analysis
por: Xiao, Siyao, et al.
Publicado: (2020)

A case report: The efficacy of pirfenidone in a Chinese patient with progressive systemic sclerosis-associated interstitial lung disease: A CARE-compliant article
por: Huang, Hui, et al.
Publicado: (2016)

Using bioinformatics approach identifies key genes and pathways in idiopathic pulmonary fibrosis
por: Xu, Zhongbo, et al.
Publicado: (2020)

Increased frequency of angiotensin converting enzyme D allele in Chinese Han patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis
por: Wu, Xiaozheng, et al.
Publicado: (2022)

Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
por: Sun, Tong, et al.
Publicado: (2016)

A retrospective study of in-hospital mortality in patients with idiopathic pulmonary fibrosis between 2015 and 2018
por: Durheim, Michael T., et al.
Publicado: (2020)

ANCA-associated vasculitis in idiopathic pulmonary fibrosis: A case report and brief review of the literature
por: Traila, Daniel, et al.
Publicado: (2022)

Right ventricular contractility decreases during exercise in patients with non-advanced idiopathic pulmonary fibrosis
por: Cobra, Sandra de Barros, et al.
Publicado: (2021)

A novel prognostic index based on the analysis of glycolysis-related genes in idiopathic pulmonary fibrosis
por: Li, Yu, et al.
Publicado: (2023)

Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis: A systematic review and meta-analysis
por: Wang, Kai, et al.
Publicado: (2017)

A score without diffusion capacity of the lung for carbon monoxide for estimating survival in idiopathic pulmonary fibrosis
por: Fukuda, Cesar Yoshito, et al.
Publicado: (2020)

The clinical efficacy of a mixture of ivy leaf extract and coptidis rhizome in patients with idiopathic pulmonary fibrosis
por: Lee, Jae Ha, et al.
Publicado: (2023)

Tonsillar Metastasis of Small Cell Lung Cancer in a Patient With Idiopathic Pulmonary Fibrosis: A Case Report
por: Kim, Eo Jin, et al.
Publicado: (2015)

Suspected accelerated disease progression after discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: Two case reports
por: Okamori, Satoshi, et al.
Publicado: (2017)

Clinical characteristics of non-idiopathic pulmonary fibrosis, progressive fibrosing interstitial lung diseases: A single-center retrospective study
por: Komatsu, Masamichi, et al.
Publicado: (2021)

Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: A review
por: Hou, Yuan, et al.
Publicado: (2023)

The effect of lung-conduction exercise in chronic obstructive pulmonary disease: Randomized, assessor-blind, multicenter pilot trial
por: Lee, Su Won, et al.
Publicado: (2022)

The safety and efficacy of alfentanil-based induction in bronchoscopy sedation: A randomized, double-blind, controlled trial
por: Hsieh, Chung-Hsing, et al.
Publicado: (2016)

Comparisons of Prognosis between Surgically and Clinically Diagnosed Idiopathic Pulmonary Fibrosis Using Gap Model: A Korean National Cohort Study
por: Lee, Sang Hoon, et al.
Publicado: (2016)

Traditional Chinese medicine for the treatment of pulmonary fibrosis: A protocol for systematic review and meta-analysis of overview
por: Li, Li-Juan, et al.
Publicado: (2020)

Cardiac septic pulmonary embolism: A retrospective analysis of 20 cases in a Chinese population
por: Song, Xin yu, et al.
Publicado: (2016)

The effect of lung-conduction exercise in chronic obstructive pulmonary disease: Study protocol for randomized, assessor-blind, multicenter trial
por: Lee, Su Won, et al.
Publicado: (2020)

Efficacy of exercise in patients with pulmonary fibrosis: A systematic review and meta-analysis
por: Gao, Yan, et al.
Publicado: (2022)

Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations
por: Zhu, Qing-Qing, et al.
Publicado: (2015)

Steroid therapy and outcome of parapneumonic pleural effusions (STOPPE): Study protocol for a multicenter, double-blinded, placebo-controlled randomized clinical trial
por: Fitzgerald, Deirdre B., et al.
Publicado: (2019)

Pirfenidone treatment of idiopathic pulmonary fibrosis
por: Gan, Ye, et al.
Publicado: (2011)

Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
por: Aimo, Alberto, et al.
Publicado: (2022)

Efficacy and safety of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis caused by novel coronavirus disease: A protocol for Bayesian network meta-analysis
por: Li, Feiran, et al.
Publicado: (2021)

Exercise-based pulmonary rehabilitation for a post-COVID-19 pulmonary fibrosis patient: A case report
por: Choi, Kyungyeul, et al.
Publicado: (2021)

A CARE-compliant case report: Lung transplantation for a Chinese young man with idiopathic pleuroparenchymal fibroelastosis
por: Huang, Hui, et al.
Publicado: (2017)

Clinical features and diagnosis of chronic pulmonary aspergillosis in Chinese patients
por: Hou, Xiaomeng, et al.
Publicado: (2017)

Prognostic significance of pulmonary hypertension in patients with cystic fibrosis: A systematic review and meta-analysis
por: Li, Diandian, et al.
Publicado: (2018)

Clinical characteristics and outcomes of post-COVID-19 pulmonary fibrosis: A case-control study
por: Farghaly, Shereen, et al.
Publicado: (2022)

The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
por: Cottin, Vincent
Publicado: (2013)

Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
por: Takeda, Yoshito, et al.
Publicado: (2014)

The association study of Apolipoprotein E polymorphisms and chronic obstructive pulmonary disease in the Chinese population: A case-control study
por: Zhang, Yuan, et al.
Publicado: (2020)

Mechanism of Polygonum capitatum intervention in pulmonary fibrosis based on network pharmacology and molecular docking technology: A review
por: Fan, Zhiliang, et al.
Publicado: (2023)

Traditional Chinese medicine may reduce the dosage of systemic glucocorticoids in required patients with acute exacerbation of chronic obstructive pulmonary disease: Study protocol for a randomized placebo-controlled trial
por: Zhao, Keni, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k7u836ln3njoikrtu2vdtg5uql